Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/85571
Citations | ||
Scopus | Web of Science® | Altmetric |
---|---|---|
?
|
?
|
Type: | Journal article |
Title: | Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX |
Author: | Collins-Praino, L. Galtieri, D. Brennum, L. Sager, T. Hockemeyer, J. Muller, C. Hinman, J. Chrobak, J. Salamone, J. |
Citation: | Pharmacology, Biochemistry and Behavior, 2010; 94(4):561-569 |
Publisher: | Pergamon-Elsevier Science |
Issue Date: | 2010 |
ISSN: | 0091-3057 1873-5177 |
Statement of Responsibility: | Lyndsey E. Collins, Daniel J. Galtieri, Lise T. Brennum, Thomas N. Sager, Jörg Hockemeyer, Christa E. Müller, James R. Hinman, James J. Chrobak, John D. Salamone |
Abstract: | Tremulous jaw movements in rats, which can be induced by dopamine (DA) antagonists, DA depletion, and cholinomimetics, have served as a useful model for studies of tremor. Although adenosine A(2A) antagonists can reduce the tremulous jaw movements induced by DA antagonists and DA depletion, there are conflicting reports about the interaction between adenosine antagonists and cholinomimetic drugs. The present studies investigated the ability of adenosine antagonists to reverse the tremorogenic effect of the muscarinic agonist pilocarpine. While the adenosine A(2A) antagonist MSX-3 was incapable of reversing the tremulous jaw movements induced by the 4.0mg/kg dose of pilocarpine, both MSX-3 and the adenosine A(2A) antagonist SCH58261 reversed the tremulous jaw movements elicited by 0.5mg/kg pilocarpine. Systemic administration of the adenosine A(1) antagonist DPCPX failed to reverse the tremulous jaw movements induced by either an acute 0.5mg/kg dose of the cholinomimetic pilocarpine or the DA D2 antagonist pimozide, indicating that the tremorolytic effects of adenosine antagonists may be receptor subtype specific. Behaviorally active doses of MSX-3 and SCH 58261 showed substantial in vivo occupancy of A(2A) receptors, but DPCPX did not. The results of these studies support the use of adenosine A(2A) antagonists for the treatment of tremor. |
Keywords: | Parkinsonism; tremor; neostriatum; invivo binding; acetylcholine; dopamine |
Rights: | © 2009 Elsevier Inc. All rights reserved. |
DOI: | 10.1016/j.pbb.2009.11.011 |
Published version: | http://dx.doi.org/10.1016/j.pbb.2009.11.011 |
Appears in Collections: | Aurora harvest 2 Psychology publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.